INTECH Investment Management’s Neuropace NPCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-14,572
Closed -$162K 2480
2025
Q2
$162K Buy
+14,572
New +$182K ﹤0.01% 2158

Other funds holding NPCE

INTECH Investment Management's NPCE Position: Q3 2025 in Review

INTECH Investment Management sold out of Neuropace (NPCE) in Q3 2025, closing a stake of 14,572 shares — an estimated $162K sold.

INTECH Investment Management first reported a position in NPCE in Q2 2025 and held it in 1 quarter. The position peaked at $162K in Q2 2025. 80 funds tracked by Wall St. Rank hold NPCE as of Q3 2025.

  • INTECH Investment Management reported no remaining Neuropace position as of Q3 2025 after selling out during the quarter.
  • INTECH Investment Management sold 14,572 Neuropace shares in Q3 2025, an estimated $162K.
  • INTECH Investment Management first reported a position in Neuropace in Q2 2025 and held it in 1 quarter.
  • INTECH Investment Management's Neuropace position peaked at $162K in Q2 2025.
  • 80 funds tracked by Wall St. Rank held Neuropace as of Q3 2025.

Based on INTECH Investment Management's 13F filing for Q3 2025, filed 12 Nov 2025.